Related references
Note: Only part of the references are listed.Arbidol as a broad-spectrum antiviral: An update
Julie Blaising et al.
ANTIVIRAL RESEARCH (2014)
Disease Severity Is Associated with Differential Gene Expression at the Early and Late Phases of Infection in Nonhuman Primates Infected with Different H5N1 Highly Pathogenic Avian Influenza Viruses
Yukiko Muramoto et al.
JOURNAL OF VIROLOGY (2014)
Suppressor of Cytokine Signaling 4 (SOCS4) Protects against Severe Cytokine Storm and Enhances Viral Clearance during Influenza Infection
Lukasz Kedzierski et al.
PLOS PATHOGENS (2014)
Characteristics of human infection with avian influenza viruses and development of new antiviral agents
Qiang Liu et al.
ACTA PHARMACOLOGICA SINICA (2013)
Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection
Qiang Liu et al.
ACTA PHARMACOLOGICA SINICA (2013)
Treating influenza with statins and other immunomodulatory agents
David S. Fedson
ANTIVIRAL RESEARCH (2013)
Hyperimmune IV Immunoglobulin Treatment A Multicenter Double-Blind Randomized Controlled Trial for Patients With Severe 2009 Influenza A(H1N1) Infection
Ivan F. N. Hung et al.
CHEST (2013)
Potential Mechanisms of AT1 Receptor Blockers on Reducing Pneumonia-Related Mortality
Karen A. Nahmod et al.
CLINICAL INFECTIOUS DISEASES (2013)
Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo
Qiang Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Antigen-Specific Memory Regulatory CD4+Foxp3+ T Cells Control Memory Responses to Influenza Virus Infection
Erik L. Brincks et al.
JOURNAL OF IMMUNOLOGY (2013)
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
Hai-Nv Gao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection
Michael B. A. Oldstone et al.
VIROLOGY (2013)
Drugs to cure avian influenza infection - multiple ways to prevent cell death
S. Yuan
CELL DEATH & DISEASE (2013)
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
Jia-xin Ling et al.
ACTA PHARMACOLOGICA SINICA (2012)
Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes
Eric M. Mortensen et al.
CLINICAL INFECTIOUS DISEASES (2012)
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases
P. Zarogoulidis et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Integrated Clinical, Pathologic, Virologic, and Transcriptomic Analysis of H5N1 Influenza Virus-Induced Viral Pneumonia in the Rhesus Macaque
Kyoko Shinya et al.
JOURNAL OF VIROLOGY (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Systemic Corticosteroids and Early Administration of Antiviral Agents for Pneumonia with Acute Wheezing due to Influenza A(H1N1)pdm09 in Japan
Koichiro Kudo et al.
PLOS ONE (2012)
Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome
Christian Brun-Buisson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection
John R. Teijaro et al.
CELL (2011)
Immunomodulatory therapy for severe influenza
Ilyse Darwish et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells
Matthew J. Kesic et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
CCR2-Antagonist Prophylaxis Reduces Pulmonary Immune Pathology and Markedly Improves Survival during Influenza Infection
Kaifeng Lisa Lin et al.
JOURNAL OF IMMUNOLOGY (2011)
Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia
Diego Viasus et al.
JOURNAL OF INFECTION (2011)
Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy
Min Yao et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression
Martin Michaelis et al.
PLOS ONE (2011)
Chinese Herbal Medicines for the Treatment of Type A H1N1 Influenza: A Systematic Review of Randomized Controlled Trials
Wei Chen et al.
PLOS ONE (2011)
N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus
Janina Geiler et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Host response to influenza virus: protection versus immunopathology
J. S. M. Peiris et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Lisa M. Alleva et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2010)
Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice
Carson E. Moseley et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2010)
Lethal Dissemination of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of Infection
Cristian Cilloniz et al.
JOURNAL OF VIROLOGY (2010)
Structured regulation of inflammation during respiratory viral infection
Tracy Hussell et al.
LANCET INFECTIOUS DISEASES (2010)
Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
Michelle A. Carey et al.
PLOS ONE (2010)
PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
Josep Bassaganya-Riera et al.
VIRAL IMMUNOLOGY (2010)
Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice
Zeyu Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice
T. Xu et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury
Chilakamarti V. Ramana et al.
MOLECULAR IMMUNOLOGY (2009)
Innate immune responses to influenza A H5N1: friend or foe?
Joseph Sriyal Malik Peiris et al.
TRENDS IN IMMUNOLOGY (2009)
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
Jesus F. Bermejo-Martin et al.
CRITICAL CARE (2009)
Genetic insights into sepsis: What have we learned and how will it help?
M. M. Wurfel
CURRENT PHARMACEUTICAL DESIGN (2008)
A calculated response: control of inflammation by the innate immune system
Gregory M. Barton
JOURNAL OF CLINICAL INVESTIGATION (2008)
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Bo-Jian Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Recognition of microorganisms and activation of the immune response
Ruslan Medzhitov
NATURE (2007)
Increased survival after gemfibrozil treatment of severe mouse influenza
Alison Budd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection
Rachelle Salomon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection
A. Garozzo et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2007)
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice
Kristy J. Szretter et al.
JOURNAL OF VIROLOGY (2007)
A question of self-preservation: immunopathology in influenza virus infection
Nicole L. La Gruta et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
Menno D. de Jong et al.
NATURE MEDICINE (2006)
1918 influenza: the mother of all pandemics
JK Taubenberger et al.
EMERGING INFECTIOUS DISEASES (2006)
Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: A self-control study
PMK Poon et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2006)
Current concepts - Avian influenza A (H5N1) infection in humans
H Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Inhibition of influenza A virus replication by resveratrol
AT Palamara et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A critical role for OX40 in T cell-mediated immunopathology during lung viral infection
IR Humphreys et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
J Bayry et al.
NEUROLOGICAL SCIENCES (2003)
Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy
T Ichiyama et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus
TC Dawson et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
